Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.
Wang
Amy T
AT
Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
McCoy
Christopher P
CP
Murad
Mohammad Hassan
MH
Montori
Victor M
VM
D016265:Conflict of Interest; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000188:drug therapy*; D030881:Disclosure; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D012307:Risk Factors; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone